Literature DB >> 21722256

Phenotypic identification of over 1000 isolates of anaerobic bacteria recovered between 1999 and 2008 in a major Costa Rican hospital.

E Rodríguez-Cavallini1, P Vargas, C Rodríguez, C Quesada-Gómez, M-M Gamboa-Coronado.   

Abstract

Because of limitations in infrastructure, the aetiology of infections caused by anaerobic bacteria is seldom determined in clinical laboratories of developing countries. This study reports on the identification of 1010 anaerobic bacterial isolates collected between 1999 and 2008 in a major Costa Rican hospital with the use of two commercial phenotypic systems (RapID 32A and API 20A). Approximately 60% of the isolates were Gram-positive and, among the 35 species of Gram-positive bacteria found, the genera Clostridium, Propionibacterium and Eggerthella, and anaerobic cocci predominated. Twenty eight species were found among 395 isolates of Gram-negative bacteria. Species of Bacteroides were very frequent, followed by species of Prevotella, Veillonella, Fusobacterium and Porphyromonas.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21722256     DOI: 10.1111/j.1469-0691.2010.03419.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  2 in total

1.  Difficulties in identifying the bacterial species from the genus Clostridium in a case of injury-related osteitis.

Authors:  Marta Kierzkowska; Piotr Pędzisz; Ireneusz Babiak; Jakub Janowicz; Mateusz Kulig; Anna Majewska; Anna Sawicka-Grzelak; Grażyna Młynarczyk
Journal:  Folia Microbiol (Praha)       Date:  2018-03-09       Impact factor: 2.099

2.  Intra-Genomic Heterogeneity in 16S rRNA Genes in Strictly Anaerobic Clinical Isolates from Periodontal Abscesses.

Authors:  Jiazhen Chen; Xinyu Miao; Meng Xu; Junlin He; Yi Xie; Xingwen Wu; Gang Chen; Liying Yu; Wenhong Zhang
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.